Role of costimulatory pathways in the pathogenesis of multiple sclerosis and experimental autoimmune encephalomyelitis

被引:48
作者
Chitnis, T [1 ]
Khoury, SJ [1 ]
机构
[1] Harvard Univ, Sch Med, Brigham & Womens Hosp, Boston, MA 02115 USA
关键词
B7-1; B7-2; CD28; CD40; CD137 (4-IBB); CD154; (CD40 ligand); costimulation; CTLA-4 (CD152); CTLA41g; experimental autoimmune encephalomyelitis; inducible costimulatory molecule; multiple sclerosis; programmed death pathway 1; programmed death pathway ligand 1; programmed death pathway ligand 2; OX40 (CD134); OX40 ligand (CD134L); MYELIN BASIC-PROTEIN; EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; CENTRAL-NERVOUS-SYSTEM; T-CELL PROLIFERATION; NECROSIS-FACTOR-ALPHA; LONG-TERM SURVIVAL; B-CELL; OX40; LIGAND; MONOCLONAL-ANTIBODY; IN-VITRO;
D O I
10.1016/j.jaci.2003.08.025
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Multiple sclerosis is an immune-mediated disorder of the central nervous system. T lymphocytes are thought to play a central role in the initiation and potentially in the propagation of this disease. Two signals are required for T-cell activation. The first signal consists of the interaction of the T-cell receptor with antigen presented by the MHC molecule on antigen-presenting cells. The second signal requires engagement of costimulatory receptors on T cells with their ligands on antigen-presenting cells. Several costimulatory pathways have been shown to play an important role in T-lymphocyte activation. Here we will review the current literature on the contribution of the B7-1/2-CD28/CTLA-4, inducible costimulatory molecule-B7h, programmed death pathway 1-programmed death pathway ligand 1/ligaDd 2, CD40-CD154, OX40-OX40 ligand, and CD137-CD137 ligand pathways to the pathogenesis of multiple sclerosis and their potential roles as therapeutic targets.
引用
收藏
页码:837 / 849
页数:13
相关论文
共 171 条
[1]   Blockade of T lymphocyte costimulation with cytotoxic T lymphocyte-associated antigen 4-immunoglobulin (CTLA4Ig) reverses the cellular pathology of psoriatic plaques, including the activation of keratinocytes, dendritic cells, and endothelial cells [J].
Abrams, JR ;
Kelley, SL ;
Hayes, E ;
Kikuchi, T ;
Brown, MJ ;
Kang, SW ;
Lebwohl, MG ;
Guzzo, CA ;
Jegasothy, BV ;
Linsley, PS ;
Krueger, JG .
JOURNAL OF EXPERIMENTAL MEDICINE, 2000, 192 (05) :681-693
[2]   Expression of the PD-1 antigen on the surface of stimulated mouse T and B lymphocytes [J].
Agata, Y ;
Kawasaki, A ;
Nishimura, H ;
Ishida, Y ;
Tsubata, T ;
Yagita, H ;
Honjo, T .
INTERNATIONAL IMMUNOLOGY, 1996, 8 (05) :765-772
[3]  
Akiba H, 1999, J IMMUNOL, V162, P7058
[4]   T-cell regulation by CD28 and CTLA-4 [J].
Alegre, ML ;
Frauwirth, KA ;
Thompson, CB .
NATURE REVIEWS IMMUNOLOGY, 2001, 1 (03) :220-228
[5]  
Arima T, 1996, J IMMUNOL, V156, P4916
[6]   MOLECULAR-CLONING OF A CD28 CDNA BY A HIGH-EFFICIENCY COS CELL EXPRESSION SYSTEM [J].
ARUFFO, A ;
SEED, B .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1987, 84 (23) :8573-8577
[7]   Increased interleukin 12 production in progressive multiple sclerosis: Induction by activated CD4(+) T cells via CD40 ligand [J].
Balashov, KE ;
Smith, DR ;
Khoury, SJ ;
Hafler, DA ;
Weiner, HL .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (02) :599-603
[8]   CD40 engagement stimulates IL-12 p70 production by human microglial cells: basis for Th1 polarization in the CNS [J].
Becher, B ;
Blain, M ;
Antel, JP .
JOURNAL OF NEUROIMMUNOLOGY, 2000, 102 (01) :44-50
[9]   The clinical course of experimental autoimmune encephalomyelitis and inflammation is controlled by the expression of CD40 within the central nervous system [J].
Becher, B ;
Durell, BG ;
Miga, AV ;
Hickey, WF ;
Noelle, RJ .
JOURNAL OF EXPERIMENTAL MEDICINE, 2001, 193 (08) :967-974
[10]  
Begolka WS, 1998, J IMMUNOL, V161, P4437